HGH and Hypoglycemia!????
- Thread starter Gaba77
- Start date
Cobra Strike
New member
^^^^this..
up your doses slower bro...add 1iu every 5 days....and eat a pb&j when you get the shakes...that will help your sugar levels come up nice and slow....its what we give hypos in the field when they go into a shock such as what you experienced
up your doses slower bro...add 1iu every 5 days....and eat a pb&j when you get the shakes...that will help your sugar levels come up nice and slow....its what we give hypos in the field when they go into a shock such as what you experienced
THE-DET-OAK
IncreasedMyT @ ULV
i just saw a study the other day implying that growth hormone optimization has the potential to make you diabetic, let me see if i can find it.
pagal aadmi
New member
shut the fuck up...got it ??
he might have used higher dosage of HGH at a time.
and lol at peoples who doesnt compete and use growth hormone to look decent.
LMAO.
what a bunch of loosers.
pagal aadmi
New member
lol...and what is OAK ?? a looser who talk all day long on site and giving shitty advice to stranger to feel good about himself ??
and that "shut the fuck up also applied to you now" lol
and that "shut the fuck up also applied to you now" lol
THE-DET-OAK
IncreasedMyT @ ULV
pagal aadmi
New member
good to see you ladies supporting each other here.
nice.
nice.
THE-DET-OAK
IncreasedMyT @ ULV
from Dr. Scally- He did note there were a lot of facts missing form this story, still interesting though.
New Onset Diabetes Associated With Bovine Growth Hormone And Testosterone Abuse
Geraci MJ, Cole M, Davis P. New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder.
New onset diabetes associated with bovine growth h... [Hum Exp Toxicol. 2011] - PubMed result
Case: A 33-year-old male presented to the emergency department with complaints of polydipsia, polyuria, nausea, headaches, blurry vision and malaise. Lab work revealed a serum glucose level of 1166 mg/dl (64.8 mmol/L). The patient admitted to completing a cycle of androgenic anabolic steroids (AASs) for bodybuilding. His regimen consisted of supraphysiologic intramuscular injections of a bovine growth hormone, trenbolone acetate and testosterone. The patient received intravenous fluids and insulin to restore metabolic balance. Previously healthy with a non-contributory family history, he was diagnosed with new onset diabetes.
Discussion: It has been demonstrated that AAS use, specifically growth hormone, can affect glucose homeostasis through increasing cellular insulin resistance and reducing glucose uptake. Excess growth hormone has been shown to cause symptoms of acromegaly which predisposes up to 40% of patients to diabetes. As trenbolone acetate is not indicated for human use and athletes are known to use supraphysiologic doses of this underground, performance enhancing drug, the correlation of the timing of events and the use of this veterinary growth hormone likely exacerbated an underlying condition or caused this new onset diabetes.
Conclusion: We report a case of a young bodybuilder with no significant past medical history who was diagnosed with new onset diabetes associated with supraphysiologic self-injections of the bovine growth hormone, trenbolone acetate, combined with testosterone. AAS have the potential to induce or exacerbate diabetic conditions due to decreased glucose tolerance and increased insulin resistance.
New Onset Diabetes Associated With Bovine Growth Hormone And Testosterone Abuse
Geraci MJ, Cole M, Davis P. New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder.
New onset diabetes associated with bovine growth h... [Hum Exp Toxicol. 2011] - PubMed result
Case: A 33-year-old male presented to the emergency department with complaints of polydipsia, polyuria, nausea, headaches, blurry vision and malaise. Lab work revealed a serum glucose level of 1166 mg/dl (64.8 mmol/L). The patient admitted to completing a cycle of androgenic anabolic steroids (AASs) for bodybuilding. His regimen consisted of supraphysiologic intramuscular injections of a bovine growth hormone, trenbolone acetate and testosterone. The patient received intravenous fluids and insulin to restore metabolic balance. Previously healthy with a non-contributory family history, he was diagnosed with new onset diabetes.
Discussion: It has been demonstrated that AAS use, specifically growth hormone, can affect glucose homeostasis through increasing cellular insulin resistance and reducing glucose uptake. Excess growth hormone has been shown to cause symptoms of acromegaly which predisposes up to 40% of patients to diabetes. As trenbolone acetate is not indicated for human use and athletes are known to use supraphysiologic doses of this underground, performance enhancing drug, the correlation of the timing of events and the use of this veterinary growth hormone likely exacerbated an underlying condition or caused this new onset diabetes.
Conclusion: We report a case of a young bodybuilder with no significant past medical history who was diagnosed with new onset diabetes associated with supraphysiologic self-injections of the bovine growth hormone, trenbolone acetate, combined with testosterone. AAS have the potential to induce or exacerbate diabetic conditions due to decreased glucose tolerance and increased insulin resistance.
Last edited:
THE-DET-OAK
IncreasedMyT @ ULV
Prevalence and Incidence of Diabetes Mellitus on Growth Hormone Replacement
According to a study published online May 4 in the Journal of Clinical Endocrinology and Metabolism, the "incidence of diabetes in adults taking growth hormone replacement (GHR) is not significantly higher than that of controls." After assessing "incidence of diabetes over 4.1 years in 5,839 patients" and a like number of controls, researchers concluded that the "increased incidence of diabetes mellitus during GHR therapy is associated with the continuing presence of obesity and metabolic syndrome rather than GHR therapy, per se."
Attanasio AF, Jung H, Mo D, et al. Prevalence and Incidence of Diabetes Mellitus in Adult Patients on Growth Hormone Replacement for Growth Hormone Deficiency: a Surveillance Database Analysis. J Clin Endocrinol Metab:jc.2011-0448. Prevalence and Incidence of Diabetes Mellitus in Adult Patients on Growth Hormone Replacement for Growth Hormone Deficiency: a Surveillance Database Analysis
Context: GH replacement in adult GH-deficient patients may cause insulin resistance, raising concerns of potential increased risk of developing diabetes mellitus (DM).
Objective: Our objective was to assess DM prevalence and incidence in the international Hypopituitary Control and Complications Study (HypoCCS) surveillance database.
Design and Participants: GH-treated patients enrolled into HypoCCS (2922 U.S. and 3709 European patients) were assessed for DM, defined as recorded on the clinical report form, reported as adverse events, fasting glucose at least 7 mmol/liter recorded at least twice, or insulin treatment reported.
Results: DM prevalence was 8.2% [95% confidence interval (CI) = 7.6–8.9] overall, 11.3% in the United States and 5.7% in Europe. Incidence (n/1000 patient-years) was 9.7 (95% CI = 8.4–10.9) overall, 14.1 (11.5–16.7) in the United States, and 7.0 (5.6–8.3) in Europe. Overall incidence was 2.1 (0.9–3.3) for patients with body mass index (BMI) below 25 kg/m2 increasing to 16.4 (13.7–19.1) for BMI over 30 kg/m2. Obesity (BMI > 30 kg/m2) prevalence was higher in the United States than Europe and higher in U.S. patients than a U.S. reference population. After age, gender, and BMI adjustment, U.S. HypoCCS DM incidence was 10.6 (8.1–13.0), compared with 7.1 (6.0–8.1) in the National Health Interview Survey. In Europe, incidence for French and German patients was comparable to reference populations; for Sweden, the point estimate was higher than the reference population, but 95% CI overlapped. GH dose was not correlated with DM incidence.
Conclusions: The present analysis showed no evidence for increased DM incidence in GH-treated adult hypopituitary patients. However, those more prone to develop DM exhibited a higher than normal prevalence of obesity.
According to a study published online May 4 in the Journal of Clinical Endocrinology and Metabolism, the "incidence of diabetes in adults taking growth hormone replacement (GHR) is not significantly higher than that of controls." After assessing "incidence of diabetes over 4.1 years in 5,839 patients" and a like number of controls, researchers concluded that the "increased incidence of diabetes mellitus during GHR therapy is associated with the continuing presence of obesity and metabolic syndrome rather than GHR therapy, per se."
Attanasio AF, Jung H, Mo D, et al. Prevalence and Incidence of Diabetes Mellitus in Adult Patients on Growth Hormone Replacement for Growth Hormone Deficiency: a Surveillance Database Analysis. J Clin Endocrinol Metab:jc.2011-0448. Prevalence and Incidence of Diabetes Mellitus in Adult Patients on Growth Hormone Replacement for Growth Hormone Deficiency: a Surveillance Database Analysis
Context: GH replacement in adult GH-deficient patients may cause insulin resistance, raising concerns of potential increased risk of developing diabetes mellitus (DM).
Objective: Our objective was to assess DM prevalence and incidence in the international Hypopituitary Control and Complications Study (HypoCCS) surveillance database.
Design and Participants: GH-treated patients enrolled into HypoCCS (2922 U.S. and 3709 European patients) were assessed for DM, defined as recorded on the clinical report form, reported as adverse events, fasting glucose at least 7 mmol/liter recorded at least twice, or insulin treatment reported.
Results: DM prevalence was 8.2% [95% confidence interval (CI) = 7.6–8.9] overall, 11.3% in the United States and 5.7% in Europe. Incidence (n/1000 patient-years) was 9.7 (95% CI = 8.4–10.9) overall, 14.1 (11.5–16.7) in the United States, and 7.0 (5.6–8.3) in Europe. Overall incidence was 2.1 (0.9–3.3) for patients with body mass index (BMI) below 25 kg/m2 increasing to 16.4 (13.7–19.1) for BMI over 30 kg/m2. Obesity (BMI > 30 kg/m2) prevalence was higher in the United States than Europe and higher in U.S. patients than a U.S. reference population. After age, gender, and BMI adjustment, U.S. HypoCCS DM incidence was 10.6 (8.1–13.0), compared with 7.1 (6.0–8.1) in the National Health Interview Survey. In Europe, incidence for French and German patients was comparable to reference populations; for Sweden, the point estimate was higher than the reference population, but 95% CI overlapped. GH dose was not correlated with DM incidence.
Conclusions: The present analysis showed no evidence for increased DM incidence in GH-treated adult hypopituitary patients. However, those more prone to develop DM exhibited a higher than normal prevalence of obesity.
RA64
I am banned!
Yo Ass Clown look at the number of friends Oak has then look how many you have.
Don't look like you will be making any new friends on here.
Beyoung
New member
Diet Ok
I believe I saw some where you are a rep for a clinic. I tried to PM you but I do not have privileges. Could you please pm me your email address. I am wanting to mabey switch clinics.
Thank you in advance for your coopeation!
I believe I saw some where you are a rep for a clinic. I tried to PM you but I do not have privileges. Could you please pm me your email address. I am wanting to mabey switch clinics.
Thank you in advance for your coopeation!
pagal aadmi
New member
online friends ?? are you serious mr. pothead ?? i"ll fuck any online friend"s mother (including your mother ) while he type a post here...i care about online friends that much.
come to reality....get out of your room
....and knock the door while you come back,..i want to spend some quality time with your mother 
mess with me again..and its gonna be real nasty for you and your homosexual cam to cam friend the diet OAk......just try.
and ohh yeah....i dont give a fuck about getting banned or online friends
hope that helps
Last edited:
Cobra Strike
New member
online friends ?? are you serious mr. pothead ?? i"ll fuck any online friend"s mother (including your mother ) while he type a post here...i care about online friends that much.
come to reality....get out of your room
mess with me again..and its gonna be real nasty for you and your homosexual cam to cam friend the diet OAk......just try.
and ohh yeah....i dont give a fuck about getting banned or online friends
hope that helps
You must be nuts....first off your talking shit about online friends but then you threaten that it will get nasty if someone talks shit to you....explain how you can do anything to anyone over the computer?
second....everytime you talk shit you smile or wink after words....wtf is that? are you pissed or are you happy...confusing
third....calm down and have some respect cause nobody really needs to deal with internet tough guys
pagal aadmi
New member
coolhandjames
I am b@nned !
^^^^ screw ball ^^^^
pagal aadmi
New member
^^^ i would like to screw you mother actually ^^^
after taking tren+prop+proviron combo...
after taking tren+prop+proviron combo...
Last edited:
Similar threads
